Target intelligence / Profile preview

Ribosomal protein L12 pseudogene 27 (RPL12P27)

Target: RPL12P27
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L12 pseudogene 27 (RPL12P27) is a processed pseudogene found in the human genome, related to the ribosomal protein L12 gene (RPL12). Pseudogenes like RPL12P27 are gene copies that have lost their ability to encode functional proteins due to mutations or lack of regulatory elements. They are generally non-functional and do not participate in normal protein synthesis or cellular pathways[2][3][5]. There is no evidence to suggest this pseudogene plays a direct role in disease, drug-response, or regulatory biology, nor is it classified as a therapeutic target. This pseudogene should not be used as a canonical therapeutic target in structured databases.

Other names: RPL12_9_1087[2]

Beyond the preview

Go deeper on Ribosomal protein L12 pseudogene 27 (RPL12P27).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L12 pseudogene 27 (RPL12P27).

Explore the full profile